| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 35.8 | 35.1 | 28.4 |
| Total income | 35.8 | 35.1 | 28.4 |
| Profit before exceptional items & tax | 4.0 | 4.0 | 3.3 |
| Profit before tax | 4.0 | 4.0 | 3.3 |
| Net profit | 3.0 | 3.0 | 2.5 |
| Operating margin | 11.2% | 11.4% | 11.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +20.00% |
|---|---|
| Net profit, quarter on quarter | +0.00% |
| Revenue, year on year | +26.10% |
NSE results filing, NSE: MEDISTEP. Figures extracted from the filing.
Medistep Healthcare Ltd: key numbers
- Share price
- ₹20.50
- Market cap
- ₹29.13 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹5.98 Cr
- P/E (TTM)
- 4.9×Sector 47.4×
- Promoter holding
- 68.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medistep Healthcare Ltd
All →Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.
Medistep Healthcare Other Announcement
Medistep Healthcare Limited has appointed M/s. Kapil Kumar Agarwal & Associates as Internal Auditor and M/s. Vaibhav Sharma & Associates as Secretarial Auditor.
Medistep Healthcare Board Meeting Outcome
Medistep Healthcare Limited announced the outcome of its board meeting held on August 24, 2026. Key decisions include notice for the AGM and appointment of auditors.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited has issued a notice for its 3rd Annual General Meeting (AGM) to be held on September 17, 2026. The filing includes the company's annual report.
Medistep Healthcare Merger & Restructuring
Medistep Healthcare is incorporating a wholly owned subsidiary, Genicus Healthcare Private Limited. The new entity will manufacture nutraceuticals and allopathic products in India.
Medistep Healthcare Financial Results
Medistep Healthcare Limited reported a total income of ₹70.83 Crore for FY2026. The Board approved these audited standalone results alongside an unmodified auditor's opinion.
- Value
- ₹70.83 Cr